Denali Therapeutics Inc. (DNLI) Dividend History

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

Last update 04/20/2018


Dividend Yield Summary

  2013 2014 2015 2016 2017 2018
Dividends - - - - - -
Average Price - - - - 17.97 20.30
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2018 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note
What other features would you like to see on this site? Please send us your comments: